FluoRok, a UK-based fluorochemical technology company, raised $30 million in an oversubscribed Series A funding round, Chemical Weekly reported on 9 November 2026.
The company is developing HF-free routes to fluorochemicals, an alternative to conventional hydrogen fluoride-based processing. Fluorochemicals are used in pharmaceuticals, agrochemicals, refrigerants and specialty materials.
The funding will support scaling of the technology. No further financial terms or investor names were disclosed in the report summary.
The raise comes as PFAS regulation tightens in the EU, increasing interest in safer and more sustainable fluorochemical manufacturing routes.
